Centrex, Inc. and Emergency Filtration Products, Inc. (EFP) entered into a strategic alliance to explore the marketing and distribution of their complimentary technologies. Under the terms of the alliance, both companies will focus on their individual areas of expertise while investigating potential collaborations that would serve to deliver to the marketplace complete biological filtering systems.
Centrex, Inc., in conjunction with Los Alamos National Laboratory, is developing a Bioterrorism Detection Device using Single Molecule Detection (SMD) that will be capable of detecting a variety of biological agents including smallpox and anthrax.
Emergency Filtration Products' patented core 2H Technology provides filtration efficiencies of greater than 99.9 percent at a particle size of 0.027 microns. The company is exploring the use of nanotechnologies to enhance the filtration efficiencies of their core technology in a new environmental mask designed to eradicate isolated pathogens. The environmental mask is currently being tested by an independent laboratory.
"We are very excited about the new strategic relationship between Centrex and EFP and believe that it positions both companies to offer the best in new technologies to combat the threat of exposure to biological agents" expressed Sherman Lazrus, EFP CEO and Chairman of the Board.
Source: Centrex, Inc.
